Why Iovance Biotherapeutics Stock Got Mashed on Monday

The company announced a flotation of its common shares that is potentially quite dilutive.Monday won't go down as a particularly memorable trading session on the stock market. It also won't be marked as a great day for shareholders of biotech Iovance Biotherapeutics (IOVA -5.76%). The company spooked investors with the disclosure that it's embarking on a new round of potentially dilutive capital raising.That sent the company's share price down by nearly 6% today, quite some distance down the ladder from the ...